Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Norethisterone acetate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing norethisterone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl oestradiol + norethindrone acetate 20mcg/1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinyl estradiol + norethindrone acetate 30mcg/1.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethindrone + ethinyl oestradiol + ferrous fumarte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing estradiol and norethisterone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.05mg/norethindrone acetate 0.25mg/day transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oestradiol + norethindrone acetate 1mg/0.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 2.5 microgram and norethisterone acetate 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone 170micrograms/24hours / Estradiol 50micrograms/24hours patche |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone 250micrograms/24hours / Estradiol 50micrograms/24hours patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ethinyl estradiol and norethisterone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 35 microgram and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.05mg/norethindrone acetate 0.25mg/day transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 0.05mg/norethindrone acetate 0.14mg/day transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol 30 microgram and norethisterone acetate 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Norethisterone acetate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Norethisterone acetate 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) |
Has basis of strength substance (attribute) |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 30 microgram and norethisterone acetate 1.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 30 microgram and norethisterone acetate 1.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 2.5 microgram and norethisterone acetate 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 2.5 microgram and norethisterone acetate 500 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norethisterone acetate 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone acetate 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 35 microgram and norethisterone acetate 1 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
Has precise active ingredient |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 35 microgram and norethisterone acetate 1 mg oral tablet |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) |
Has precise active ingredient |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 2.5 microgram and norethisterone acetate 500 microgram oral tablet |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Norethisterone acetate 5 mg oral tablet |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ethinylestradiol 30 microgram and norethisterone acetate 1.5 mg oral tablet |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol 2.083 microgram/hour and norethisterone acetate 7.083 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol 2.083 microgram/hour and norethisterone acetate 7.083 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
False |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 500 microgram and norethisterone acetate 100 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Estradiol 2.083 microgram/hour and norethisterone acetate 7.083 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2.083 microgram/hour and norethisterone acetate 7.083 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1 mg and norethisterone acetate 1 mg oral tablet |
Has precise active ingredient |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Estradiol 1 mg and norethisterone acetate 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Norethisterone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |